• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原位肝移植后同种异体移植物中的丙型肝炎病毒再感染

Hepatitis C virus reinfection in allografts after orthotopic liver transplantation.

作者信息

König V, Bauditz J, Lobeck H, Lüsebrink R, Neuhaus P, Blumhardt G, Bechstein W O, Neuhaus R, Steffen R, Hopf U

机构信息

Department of Internal Medicine, Universitätsklinikum Rudolf Virchow-Charlottenburg, Freie Universität Berlin, Germany.

出版信息

Hepatology. 1992 Nov;16(5):1137-43. doi: 10.1002/hep.1840160506.

DOI:10.1002/hep.1840160506
PMID:1330865
Abstract

From September 1988 to May 1991, 160 orthotopic liver transplantations were performed in our hospital. Twenty-four patients had end-stage cirrhosis caused by chronic non-A, non-B hepatitis. Antibodies against hepatitis C virus were documented before and after orthotopic liver transplantation in 13 patients. Studies using the polymerase chain reaction demonstrated hepatitis C virus RNA in the serum and liver tissue of 17 patients (10 of whom tested positive for hepatitis C virus antibodies) before orthotopic liver transplantation. Tissue samples taken from liver grafts during the operation were hepatitis C virus RNA negative in every case. Ten of these 17 patients had positive hepatitis C virus RNA findings in serum and liver biopsy specimens within the first month after surgery. One patient died of Mucor sepsis 2 mo after orthotopic liver transplantation. Another patient died of multi-organ failure 3 mo after a retransplantation. Two patients underwent retransplantation for graft rejection at 2 and 3 mo, respectively. One year after orthotopic liver transplantation, hepatitis C virus RNA was demonstrated in allograft biopsy specimens in 13 of 15 patients. Two patients remained hepatitis C virus RNA negative in repeated biopsies up to 12 mo. Mild portal and lobular hepatitis developed within 6 months of orthotopic liver transplantation in four patients and within 1 yr in five additional patients. The data suggest that persistent hepatitis C virus reinfects the allograft in most cases, but the risk of acute organ damage caused by hepatitis C virus reinfection is low.

摘要

1988年9月至1991年5月,我院共进行了160例原位肝移植手术。24例患者患有慢性非甲非乙型肝炎所致的终末期肝硬化。13例患者在原位肝移植前后均检测到抗丙型肝炎病毒抗体。聚合酶链反应研究显示,17例患者(其中10例丙型肝炎病毒抗体检测呈阳性)在原位肝移植前血清和肝组织中存在丙型肝炎病毒RNA。手术中取自肝移植物的组织样本在每例中丙型肝炎病毒RNA均为阴性。这17例患者中有10例在术后第一个月内血清和肝活检标本中丙型肝炎病毒RNA检测结果呈阳性。1例患者在原位肝移植后2个月死于毛霉菌败血症。另1例患者在再次移植后3个月死于多器官功能衰竭。2例患者分别在术后2个月和3个月因移植物排斥反应接受了再次移植。原位肝移植1年后,15例患者中有13例的同种异体肝活检标本中检测到丙型肝炎病毒RNA。2例患者在长达12个月的重复活检中丙型肝炎病毒RNA仍为阴性。4例患者在原位肝移植后6个月内、另外5例患者在1年内出现了轻度门静脉和小叶性肝炎。数据表明,在大多数情况下,丙型肝炎病毒持续感染同种异体肝,但丙型肝炎病毒再次感染导致急性器官损伤的风险较低。

相似文献

1
Hepatitis C virus reinfection in allografts after orthotopic liver transplantation.原位肝移植后同种异体移植物中的丙型肝炎病毒再感染
Hepatology. 1992 Nov;16(5):1137-43. doi: 10.1002/hep.1840160506.
2
In situ enzymatic oligonucleotide amplification of hepatitis C virus-RNA in liver biopsy specimens (reverse transcriptase in situ polymerase chain reaction) after orthotopic liver transplantation for hepatitis C-related liver disease.丙型肝炎相关肝病原位肝移植后肝活检标本中丙型肝炎病毒RNA的原位酶促寡核苷酸扩增(逆转录原位聚合酶链反应)
Transplantation. 1998 Dec 15;66(11):1472-6. doi: 10.1097/00007890-199812150-00010.
3
Serological pattern of hepatitis C virus recurrence after liver transplantation.肝移植后丙型肝炎病毒复发的血清学模式。
J Hepatol. 1996 Jan;24(1):15-20. doi: 10.1016/s0168-8278(96)80180-2.
4
Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence.原位肝移植后的丙型肝炎:再感染与疾病复发
J Hepatol. 1994 Dec;21(6):961-5. doi: 10.1016/s0168-8278(05)80602-6.
5
Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study.原位肝移植后丙型肝炎移植肝再感染的早期检测:一项分子与组织学研究
Mod Pathol. 2000 Mar;13(3):229-37. doi: 10.1038/modpathol.3880043.
6
Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histological study.
J Hepatol. 1994 Oct;21(4):536-42. doi: 10.1016/s0168-8278(94)80098-7.
7
Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.抗丙型肝炎病毒核心IgM抗体与肝移植患者丙型肝炎复发及其严重程度相关。
Gut. 2000 Nov;47(5):698-702. doi: 10.1136/gut.47.5.698.
8
Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.组织丙型肝炎病毒RNA定量和蛋白表达有助于识别肝移植后早期丙型肝炎病毒复发。
Liver Transpl. 2008 Mar;14(3):313-20. doi: 10.1002/lt.21375.
9
Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation.肝移植后急性移植物排斥反应与丙型肝炎复发感染的组织病理学比较。
Liver Transpl Surg. 1997 Jul;3(4):398-406. doi: 10.1002/lt.500030407.
10
Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.拉米夫定预防肝移植术后乙肝相关肝硬化患者肝移植肝乙肝病毒再感染
Hepatobiliary Pancreat Dis Int. 2004 Feb;3(1):26-32.

引用本文的文献

1
Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma.直接作用抗病毒疗法对肝细胞癌患者肝移植后丙型肝炎病毒复发感染的临床疗效。
World J Hepatol. 2020 Sep 27;12(9):628-640. doi: 10.4254/wjh.v12.i9.628.
2
High frequency of central memory regulatory T cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantation.中枢记忆调节性T细胞的高频率使得能够在移植后的第一个月内检测出有早期急性排斥反应风险的肝移植受者。
Int Immunol. 2016 Feb;28(2):55-64. doi: 10.1093/intimm/dxv048. Epub 2015 Aug 12.
3
Cyclosporin A, but not tacrolimus, negatively affects the hepatic extraction fraction of hepatobiliary scintigraphy in liver transplant recipients.
环孢素 A,但不是他克莫司,会对肝移植受者的肝胆闪烁显像的肝提取分数产生负面影响。
EJNMMI Res. 2014 Dec;4(1):73. doi: 10.1186/s13550-014-0073-z. Epub 2014 Dec 17.
4
The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence.mTOR抑制剂在肝移植中的作用:证据综述
J Transplant. 2014;2014:845438. doi: 10.1155/2014/845438. Epub 2014 Feb 25.
5
Prevention of hepatitis C recurrence after liver transplantation: An update.肝移植后丙型肝炎复发的预防:最新进展
World J Gastrointest Pharmacol Ther. 2012 Aug 6;3(4):36-48. doi: 10.4292/wjgpt.v3.i4.36.
6
Liver transplantation for hepatitis C and alcoholic liver disease.丙型肝炎和酒精性肝病的肝移植
J Transplant. 2010;2010:893893. doi: 10.1155/2010/893893. Epub 2010 Dec 15.
7
Histologic predictors of fibrosis progression in liver allografts in patients with hepatitis C virus infection.丙型肝炎病毒感染患者肝移植后纤维化进展的组织学预测因子。
Clin Gastroenterol Hepatol. 2010 Mar;8(3):289-96, 296.e1-8. doi: 10.1016/j.cgh.2009.10.034. Epub 2009 Nov 12.
8
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles.丙型肝炎病毒感染患者肝移植的免疫抑制:基于机制的原则
Liver Transpl. 2005 Nov;11(11):1343-52. doi: 10.1002/lt.20536.
9
Outcome of orthotopic liver transplantation in patients with hepatitis C.丙型肝炎患者原位肝移植的结果
Dig Dis Sci. 2002 Feb;47(2):450-5. doi: 10.1023/a:1013759230800.
10
HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication?慢性丙型肝炎病毒(HCV)感染患者外周血单个核细胞中HCV-RNA阳性:这真的意味着病毒复制吗?
World J Gastroenterol. 2001 Apr;7(2):228-34. doi: 10.3748/wjg.v7.i2.228.